MedPath

山东辰龙药业有限公司

Ownership
-
Established
2012-10-26
Employees
-
Market Cap
-
Website
http://www.chenlongpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Cycloclenbuterol Hydrochloride

Product Name
盐酸环仑特罗
Approval Number
国药准字H37023277
Approval Date
Apr 10, 2024
NMPA

Apraclonidine Hydrochloride

Product Name
盐酸安普乐定
Approval Number
国药准字H20050247
Approval Date
Apr 10, 2024
NMPA

Faropenem Sodium

Product Name
法罗培南钠
Approval Number
国药准字H20090148
Approval Date
Apr 10, 2024
NMPA

Mepivacaine Hydrochloride

Product Name
盐酸甲哌卡因
Approval Number
国药准字H20110073
Approval Date
Apr 9, 2024
NMPA

Mycophenolate Mofetil

Product Name
吗替麦考酚酯
Approval Number
国药准字H20067156
Approval Date
Feb 7, 2024
NMPA

Ropivacaine Mesi Late

Product Name
甲磺酸罗哌卡因
Approval Number
国药准字H20051865
Approval Date
Feb 7, 2024
NMPA

Droperidol

Product Name
氟哌利多
Approval Number
国药准字H37022301
Approval Date
Feb 7, 2024
NMPA

Alanyl Glutamine

Product Name
丙氨酰谷氨酰胺
Approval Number
国药准字H20050397
Approval Date
Feb 7, 2024
NMPA

Mecobalamin

Product Name
甲钴胺
Approval Number
国药准字H20051103
Approval Date
Feb 7, 2024
NMPA

Liranaftate

Product Name
利拉萘酯
Approval Number
国药准字H20052286
Approval Date
Jan 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.